Hot Topics: Health Regulation & Law
by Matthew Cote, MD, FACEP
As the first two major vaccinations for COVID-19 have started to be widely distributed in the United States, a disturbing trend is emerging: many healthcare workers who presumably are educated about the vaccine, are declining to receive it. …
Full Article
by Craig Klugman, Ph.D.
It is hard to know what to write in the middle of another drawn out ballot counting election in the U.S.…
Full Article
by Dorit Reiss, PhD LLB, Art Caplan, PhD, and Working Group on Vaccine Ethics and Policy
The question whether the FDA will give an Emergency Use Authorization (EUA) to a COVID-19 vaccine is currently being widely discussed. The…
Full Article
by Craig Klugman, Ph.D.
During election years, I usually blog about any health and bioethics-related issues raised during debates between candidates.…
Full Article
The Working Group on Compassionate Use and Preapproval Access (CUPA), a project of the NYU Grossman School of Medicine Division of Medical Ethics
The undersigned are members of a multidisciplinary group comprising bioethicists, clinicians, patient advocates, and representatives from industry and law who for the past seven years have been studying the ethical issues surrounding access to medical products before they have received regulatory approval.…
Full Article
by Sweta Dubey MBBS & Siddhesh Zadey BSMS
For the first time in human history, over 3.9 billion people in about ninety countries around the world were contained in lockdowns as of the first week of April.…
Full Article
by Daniel Du Pont, MD, MBE and Jill Baren, MD, MS, MBA, FACEP, FAAP
The novel coronavirus outbreak, like any pandemic, has brought with it many difficult choices.…
Full Article
by Carlo Alfredo Clerici, MD, Tullio Proserpio, PhD, Costanza Raimondi, PhD candidate
The COVID pandemic has exposed us to our own fragility and has forced the entire world to confront a condition with no cure.…
Full Article
by Anne Zimmerman, JD, candidate MS (Bioethics)
At first it seemed like violence in the US had subsided during the pandemic.…
Full Article
by Craig Klugman, Ph.D.
In 2009, after an outbreak of H1N1 flu, the Institutes of Medicine (IOM) issued a letter that encouraged all states to begin planning for a pandemic flu.…
Full ArticlePatenting Foundational Technologies: Recent Developments in the CRISPR Patent Struggle
Clearing Muddy Waters: The Need to Reconceptualize Minor Increase over Minimal Risk in Pediatric Rare Disease Research
Can the Principles of Research Ethics Help Us Distribute Clinical Resources More Fairly?
Misrepresenting “Usual Care” in Research: An Ethical and Scientific Error
Operational Characteristics of Institutional Review Boards (IRBs) in the United States
Breaking a Vital Trust: Posting Photos of Patients on Facebook Among a Sample of Peruvian Medical Students
“Paid to Endure”: Paid Research Participation, Passivity, and the Goods of Work
The Continued Complexities of Paying Research Participants
How can bioethics help software in medicine? “Bioethicists can help strengthen ethical, legal, and social analyses that identify the questions to create a good mix of both precautionary and permissive regulation.”
Full Article“Working with limited supplies and imperfect scheduling systems, many pharmacists are drowning under a flood of inquiries. Wait lists, where they exist, are getting longer. And even creative solutions are succumbing to the cold realities of the day.”
Full ArticleWhat drives vaccine hesitancy among healthcare workers? “The hesitancy is less outright rejection than cautious skepticism. It’s driven by suspicions about the evidence supporting the new vaccines and about the motives of those endorsing them.”
Full Article“Yet, design choices in the built health care environment raise substantive bioethical issues that demand the attention of bioethicists and ethical inquiry. It is time for the built environment to be considered alongside other parameters of care.”
Full ArticleA big component of vaccine distribution has been utilizing ethics to determine vaccine prioritization. Issac Chotiner of The New Yorker speaks with immunologist Barry Bloom to discuss what goes into making decisions on vaccine distribution.
Full ArticleWith efficacious medications available, ethics considers who has access to these drugs and who is at risk of losing them. Under COVID-19, the pandemic has accelerated the growth of many health disparities in the United States. Recently, there has been an increase in “pharmacy deserts”, where people struggle to fill medications locally because the drugs are no longer covered by Medicare of Medicaid.
Full ArticleThe new COVID-19 variants that have popped up in the United Kingdom and South Africa are the new obstacles to tackle in the pandemic. Will current vaccines be able to measure up against new strains? Scientists are seeking an answer.
Full ArticleWhy has vaccine distribution fallen into disarray across the United States? Lack of funding and coordination between state and local governments has left citizens confused about their vaccination opportunities. What will come in year 2 of COVID-19?
Full ArticleTesting is essential to our fight against #COVID-19. Have you thought about those that give tests to millions of Americans daily? Testing teams are grappling with burnout as these surges approach. How can we consider this population in ethics?
Full ArticleAstraZeneca recently disclosed a key mistake in their vaccine trials. How will this impact the trust and reliability of their results? What ethics needs to be considered regarding this mistake? Can these results now hold up with further testing?
Full Article